$124.1 M

OCX Mkt cap, 22-Jun-2018
OncoCyte Corporation Net income (Q1, 2018)-3.8 M
OncoCyte Corporation EBIT (Q1, 2018)-3.9 M
OncoCyte Corporation Cash, 31-Mar-201812.6 M

OncoCyte Corporation Financials

OncoCyte Corporation Income Statement

Annual

USDFY, 2016

R&D expense

5.7 m

General and administrative expense

5.5 m

Operating expense total

11.1 m

EBIT

(11.1 m)

Interest expense

28 k

Net Income

(11.2 m)

Quarterly

USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Sales and marketing expense

655 k477 k710 k658 k

R&D expense

1.7 m1.2 m1.4 m1.8 m2 m1.8 m1.5 m

General and administrative expense

1.2 m1.3 m1.2 m2 m1.1 m4.3 m1.8 m

Operating expense total

2.9 m(2.5 m)(2.6 m)4.5 m(3.6 m)(6.8 m)3.9 m

EBIT

(2.9 m)(2.5 m)(2.6 m)(4.5 m)(3.6 m)(6.8 m)(3.9 m)

Interest expense

4 k11 k13 k13 k65 k71 k60 k

Interest income

4 k11 k13 k

Net Income

(2.9 m)(2.5 m)(2.6 m)(4.7 m)(3.8 m)(6.9 m)(3.8 m)

OncoCyte Corporation Balance Sheet

Annual

USDFY, 2016

Cash

10.2 m

Accounts Receivable

14.3 m

Inventories

285 k

Current Assets

12.7 m

Total Assets

14.4 m

Accounts Payable

422 k

Current Liabilities

4.3 m

Total Liabilities

4.6 m

Retained Earnings

(35.3 m)

Total Equity

9.9 m

Financial Leverage

1.5 x

Quarterly

USDQ3, 2017Q1, 2018

Cash

11 m12.6 m

Inventories

457 k

Current Assets

12.5 m14.1 m

Total Assets

14.2 m15.6 m

Accounts Payable

307 k

Current Liabilities

4.6 m5.5 m

Total Liabilities

6.2 m6.6 m

Retained Earnings

(50.7 m)(59.3 m)

Total Equity

8 m9 m

Financial Leverage

1.8 x1.7 x

OncoCyte Corporation Cash Flow

Annual

USDFY, 2016

Net Income

(11.2 m)

Depreciation and Amortization

145 k

Inventories

101 k

Cash From Operating Activities

(7.5 m)

Purchases of PP&E

(106 k)

Cash From Investing Activities

(181 k)

Cash From Financing Activities

9.9 m

Quarterly

USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(2.9 m)(2.5 m)(2.6 m)(4.7 m)

Accounts Payable

403 k192 k870 k211 k

OncoCyte Corporation Ratios

USDY, 2018

Financial Leverage

1.7 x
Report incorrect company information

OncoCyte Corporation Operating Metrics

FY, 2016

Patents Issued

1

Patents and Patent Applications

13
Report incorrect company information